Market Capitalization (Millions $) |
15 |
Shares
Outstanding (Millions) |
398 |
Employees |
- |
Revenues (TTM) (Millions $) |
0 |
Net Income (TTM) (Millions $) |
-16 |
Cash Flow (TTM) (Millions $) |
0 |
Capital Exp. (TTM) (Millions $) |
0 |
Oncotelic Therapeutics Inc
Oncotelic Therapeutics Inc is a biopharmaceutical company that focuses on developing innovative therapies for the treatment of cancer. The company's primary goal is to create targeted drugs that can effectively inhibit the growth and spread of cancer cells while minimizing the side effects often associated with traditional chemotherapy. Oncotelic Therapeutics utilizes advanced technologies, including nanomedicine and RNA interference, to design and develop its drug candidates. These novel therapies aim to improve patient outcomes and provide new solutions in the field of oncology.
Company Address: 29397 Agoura Road Agoura Hills 91301 CA
Company Phone Number: 635-7000 Stock Exchange / Ticker: OTLC
OTLC is expected to report next financial results on April 13, 2024. |
|
|